We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Drug Free Solutions Inc (CE) | USOTC:DSOL | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0002 | 0.00 | 01:00:00 |
As filed with the Securities and Exchange Commission on October 15, 2013
Registration Nos. 333-89822; 811-21114
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form N-1A
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933 | x | |||
Pre-Effective Amendment No. | ||||
Post-Effective Amendment No. 99 | x |
and/or
REGISTRATION STATEMENT
UNDER
THE INVESTMENT COMPANY ACT OF 1940 | x | |||
Amendment No. 108 | x |
ProShares Trust
(Exact name of Registrant as Specified in Trust Instrument)
7501 Wisconsin Avenue,
Suite 1000 Bethesda, MD 20814
(Address of Principal Executive Office) (Zip Code)
(240) 497-6400
(Area Code and Telephone Number)
Michael L. Sapir, CEO
ProShare Advisors LLC
7501 Wisconsin Avenue, Suite 1000
Bethesda, MD 20814
(Name and Address of Agent for Service)
with copies to:
John Loder, Esq. c/o Ropes & Gray LLP Prudential Tower 800 Boylston Street Boston, MA 02199-3600 |
Amy R. Doberman ProShare Advisors LLC 7501 Wisconsin Avenue, Suite 1000 Bethesda, MD 20814 |
Approximate date of Proposed Public Offering:
It is proposed that this filing will become effective:
¨ | immediately upon filing pursuant to paragraph (b) |
x | on November 14, 2013 pursuant to paragraph (b)(1)(iii) of Rule 485 |
¨ | 60 days after filing pursuant to paragraph (a)(1) |
¨ | on pursuant to paragraph (a)(1) |
¨ | 75 days after filing pursuant to paragraph (a)(2) |
¨ | on (date) pursuant to paragraph (a)(2) of rule 485. |
If appropriate, check the following:
x |
This post-effective amendment designates a new effective date for a previously filed post-effective amendment. |
EXPLANATORY NOTE
The sole purpose of this filing is to delay the effectiveness of the Trusts Post-Effective Amendment No. 90 under the Securities Act of 1933 (1933 Act) and No. 99 under the Investment Company Act of 1940 (1940 Act) to its Registration Statement until November 14, 2013. Parts A, B and C of the Registrants Post-Effective Amendment No. 90 under the 1933 Act and No. 99 under 1940 Act, filed on May 31, 2013, are incorporated by reference herein.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933 and the Investment Company Act of 1940, the Registrant certifies that it meets all the requirements for effectiveness of this registration statement under rule 485(b) under the Securities Act and has duly caused this post-effective amendment (the Amendment) to its Registration Statement to be signed on its behalf by the undersigned, thereto duly authorized, in the City of Bethesda and the State of Maryland on October 15, 2013.
ProShares Trust | ||
By: | /s/ Louis M. Mayberg | |
Louis M. Mayberg |
Pursuant to the requirements of the Securities Act of 1933, this Amendment to the Registration Statement has been signed below by the following persons in the capacities indicated.
Signature |
Title |
Date | ||
/s/ Michael L. Sapir * Michael L. Sapir |
Trustee, Chairman | October 15, 2013 | ||
/s/ Russell S. Reynolds, III * Russell S. Reynolds, III |
Trustee | October 15, 2013 | ||
/s/ Michael C. Wachs * Michael C. Wachs |
Trustee | October 15, 2013 | ||
/s/ William D. Fertig* William D. Fertig |
Trustee | October 15, 2013 | ||
/s/ Louis M. Mayberg Louis M. Mayberg |
President | October 15, 2013 | ||
/s/ Charles S. Todd Charles S. Todd |
Treasurer | October 15, 2013 | ||
* By: | /s/ Amy R. Doberman | |
Amy R. Doberman As Attorney-in-fact |
Date: October 15, 2013
1 Year Drug Free Solutions (CE) Chart |
1 Month Drug Free Solutions (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions